Extension Study of MT-1303 in Subjects With Crohn's Disease
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are:
-To evaluate the long-term safety and tolerability of MT-1303 in subjects with moderate to
severe active Crohn's Disease（CD）